Healthcare Services

Psychosis Market Forecast Assessing Growth Potential And Industry Direction

June 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Psychosis Market Increase Between 2026 And 2030?

The psychosis market has demonstrated significant expansion in recent years. Its valuation is anticipated to increase from $10.46 billion in 2025 to $11.06 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.8%. This historical growth can be linked to several factors including increasing diagnosis of schizophrenia and related disorders, expansion of hospital-based psychiatric care, wider use of antipsychotic medications, growing mental health awareness, and availability of specialized mental health clinics.

The psychosis market is projected for substantial expansion in the coming years, with its size anticipated to reach $13.7 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.5%. This anticipated growth during the forecast period is propelled by factors such as increased funding for new antipsychotic drug development, a heightened emphasis on managing psychosis at its early stages, the broadening of community mental health services, the wider embrace of digital therapeutic solutions, and a surging need for managing the condition over the long term. Key developments expected within the forecast timeframe encompass a greater reliance on long-acting injectable antipsychotics, the increased implementation of early intervention initiatives, an evolving focus on integrated care frameworks, the proliferation of digital monitoring instruments for psychosis, and a stronger commitment to individualized treatment strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21266&type=smp

Which Significant Factors Are Encouraging Growth In The Psychosis Market?

The rising prevalence of mental health conditions is projected to drive expansion within the psychosis market moving forward. Mental health conditions are characterized as disorders that influence a person’s mood, thought processes, actions, and overall mental well-being. This surge in mental health cases is attributed to elevated stress levels, alterations in lifestyle, increased social isolation, economic pressures, and genetic predispositions. Psychosis treatment offers support to individuals grappling with mental health issues through timely diagnosis, medical interventions, and specialized therapeutic approaches, thereby increasing the utilization of antipsychotic medications and various therapy options. For example, in May 2024, the American Psychiatric Association, a US-based professional body comprising psychiatrists and trainee psychiatrists, reported that 43% of adults experienced heightened anxiety levels compared to the prior year, marking an increase from 37% in 2023 and 32% in 2022. Hence, the growing incidence of mental health conditions is significantly propelling the growth of the psychosis market.

How Does Segment Analysis Break Down The Psychosis Market Structure?

The psychosis market covered in this report is segmented –

1) By Product: Tablet, Capsule, Injection

2) By Disease Type: Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Disease Types

3) By Distribution Channel: Online, Offline

4) By End-User: Hospitals, Healthcare Clinics, Speciality Clinics, Other End-Users

Subsegments:

1) By Tablet: Antipsychotic Tablets, Mood Stabilizer Tablets

2) By Capsule: Antipsychotic Capsules, Antidepressant Capsules

3) By Injection: Long-acting Injectable Antipsychotics, Short-acting Injectable Antipsychotics

Which Trends Are Expected To Shape The Psychosis Market?

Leading companies within the psychiatry clinics market are concentrating on developing innovative treatment strategies, such as transcranial magnetic stimulation (TMS) therapy, to boost treatment effectiveness, expand non-invasive care alternatives, and enhance patient outcomes for mental health issues. Transcranial magnetic stimulation (TMS) therapy is defined as a non-invasive procedure that employs magnetic fields to stimulate nerve cells in the brain. For example, in August 2024, Neuro Wellness Spa, a mental healthcare company based in the US, launched its 10th Psychiatry and TMS Clinic to offer accessible and advanced mental healthcare. This 10th psychiatry and TMS clinic by Neuro Wellness Spa provides sophisticated, patient-centered mental health services, aiming to widen access to affordable and effective care. The clinic offers non-invasive transcranial magnetic stimulation (TMS) therapy for conditions such as treatment-resistant depression, anxiety, and OCD, alongside personalized treatment plans that include psychiatric evaluations, medication management, and psychotherapy services like cognitive behavioral therapy. Integrative wellness programs, featuring nutritional counseling and stress management, are also available, supporting holistic patient care. The clinic utilizes state-of-the-art TMS devices with customizable protocols to ensure precise treatment delivery in a comfortable, modern environment. Moreover, the clinic offers insurance and flexible payment options to enhance affordability, while telepsychiatry services facilitate ongoing virtual care to improve treatment continuity and patient outcomes.

Who Are The Key Market Participants In The Psychosis Market?

Major companies operating in the psychosis market are Pfizer Inc., Johnson And Johnson, AbbVie Inc., Bristol Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Dr Reddys Laboratories Ltd., Lundbeck AS, Gedeon Richter, Alkermes, Supernus Pharmaceuticals, Acadia Pharmaceuticals, Mapi Pharma, Astellas Pharma Inc., Newron Pharmaceuticals SpA, BioXcel Therapeutics, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Zydus Lifesciences Ltd.

Access The Complete Psychosis Market Report:

https://www.thebusinessresearchcompany.com/report/psychosis-global-market-report

Which Region Holds The Largest Share In The Psychosis Market?

North America was the largest region in the psychosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Psychosis Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=21266&type=smp

Browse Through More Reports Similar to the Global Psychosis Market 2026, By The Business Research Company

Lawn Mower Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lawn-mower-global-market-report

Lawn Mowers Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/lawn-mowers-global-market-report

Robotic Lawn Mower Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/robotic-lawn-mower-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795